SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-009740
Filing Date
2023-06-13
Accepted
2023-06-13 16:30:35
Documents
1
Period of Report
2023-06-12

Document Format Files

Seq Description Document Type Size
1 form4-06132023_040620.html 4  
1 form4-06132023_040620.xml 4 4105
  Complete submission text file 0001415889-23-009740.txt   5445
Mailing Address C/O AKERO THERAPEUTICS, INC. 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Heyman Tomas J. (Reporting) CIK: 0001814673 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40925 | Film No.: 231011590

Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations